To confirm that CDH17 is a better targeting molecule in gastric cancer, we first compared the mRNA expression of three markers (CDH17, HER2 and VEGFR2) in gastric cancer using Genotype Tissue Expression (GTEx) and the Cancer Genome Atlas (TCGA) databases. This evidence concerns the gene KDR and gastric cancer.